Clinical Trial Update: PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients [Phase 2]

View source ↗

Summary

Phase 2 PET/public speaking trial using a two-drug combination in social anxiety disorder has completed; results are not detailed in the provided summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depressive Disorder
• Social Anxiety Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder and Anxiety Disorders | Phase 2 | Status: COMPLETED